(CHRD) Chord Energy - Ratings and Ratios
Crude Oil, Natural Gas, Natural Gas Liquids
CHRD EPS (Earnings per Share)
CHRD Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 34.2% |
| Value at Risk 5%th | 57.2% |
| Relative Tail Risk | 1.76% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.56 |
| Alpha | -40.10 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.516 |
| Beta | 1.238 |
| Beta Downside | 1.686 |
| Drawdowns 3y | |
|---|---|
| Max DD | 53.91% |
| Mean DD | 19.38% |
| Median DD | 11.70% |
Description: CHRD Chord Energy November 05, 2025
Chord Energy Corp (NASDAQ: CHRD) is an independent U.S. upstream firm focused on the Williston Basin, where it acquires, explores, develops, and produces crude oil, natural gas, and natural gas liquids (NGLs). The company markets its output to refiners, marketers, and other buyers with access to pipeline and rail infrastructure. It rebranded from Oasis Petroleum in July 2022, but its operational footprint and corporate headquarters in Houston, Texas remain unchanged.
According to the most recent 10-K (2023), CHRD reported average daily production of roughly 30,000 barrels of oil equivalent (boe) per day, with a crude-oil-weighted mix of about 80 % oil and 20 % natural gas/NGLs. The firm generated $210 million of operating cash flow in 2023, and its net debt stood at $1.0 billion, yielding a debt-to-EBITDA ratio near 3.5×-a level that is modest for the mid-cap E&P segment but still sensitive to sustained price volatility.
Key economic drivers for CHRD include the price of West Texas Intermediate (WTI) crude, which directly affects revenue given the oil-heavy production profile, and the availability of midstream capacity in the Williston Basin, where pipeline constraints can force higher rail freight costs. A sector-wide trend worth noting is the accelerating shift toward capital efficiency: peers are increasingly prioritizing low-cost, high-margin acreage, which could pressure CHRD’s capital allocation if its acquisition pipeline does not meet the same cost discipline.
For a deeper quantitative view of CHRD’s valuation metrics, the ValueRay platform offers a granular breakdown of its cash-flow sensitivity to oil-price scenarios.
CHRD Stock Overview
| Market Cap in USD | 4,970m |
| Sub-Industry | Oil & Gas Exploration & Production |
| IPO / Inception | 2000-02-15 |
| Return 12m vs S&P 500 | -34.7% |
| Analyst Rating | 4.40 of 5 |
CHRD Dividends
| Dividend Yield | 5.74% |
| Yield on Cost 5y | 27.86% |
| Yield CAGR 5y | 21.74% |
| Payout Consistency | 74.6% |
| Payout Ratio | 44.6% |
CHRD Growth Ratios
| CAGR 3y | -9.64% |
| CAGR/Max DD Calmar Ratio | -0.18 |
| CAGR/Mean DD Pain Ratio | -0.50 |
| Current Volume | 712.7k |
| Average Volume | 712.7k |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (170.6m TTM) > 0 and > 6% of Revenue (6% = 309.7m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA -0.56pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 10.39% (prev -2.30%; Δ 12.69pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.17 (>3.0%) and CFO 2.21b > Net Income 170.6m (YES >=105%, WARN >=100%) |
| Net Debt (880.0m) to EBITDA (1.79b) ratio: 0.49 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.35 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (57.2m) change vs 12m ago -8.74% (target <= -2.0% for YES) |
| Gross Margin 41.97% (prev 28.84%; Δ 13.12pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 39.51% (prev 36.53%; Δ 2.98pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.80 (EBITDA TTM 1.79b / Interest Expense TTM 70.9m) >= 6 (WARN >= 3) |
Altman Z'' 1.37
| (A) 0.04 = (Total Current Assets 2.06b - Total Current Liabilities 1.53b) / Total Assets 13.10b |
| (B) 0.16 = Retained Earnings (Balance) 2.03b / Total Assets 13.10b |
| (C) 0.03 = EBIT TTM 340.0m / Avg Total Assets 13.07b |
| (D) 0.40 = Book Value of Equity 2.03b / Total Liabilities 5.02b |
| Total Rating: 1.37 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 61.47
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 14.78% = 5.0 |
| 3. FCF Margin 16.75% = 4.19 |
| 4. Debt/Equity 0.19 = 2.48 |
| 5. Debt/Ebitda 0.49 = 2.32 |
| 6. ROIC - WACC (= -3.97)% = -4.96 |
| 7. RoE 2.04% = 0.17 |
| 8. Rev. Trend 75.60% = 5.67 |
| 9. EPS Trend -78.04% = -3.90 |
What is the price of CHRD shares?
Over the past week, the price has changed by +6.53%, over one month by +2.49%, over three months by -8.27% and over the past year by -25.18%.
Is Chord Energy a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CHRD is around 78.07 USD . This means that CHRD is currently overvalued and has a potential downside of -16.15%.
Is CHRD a buy, sell or hold?
- Strong Buy: 9
- Buy: 3
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CHRD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 128.7 | 38.2% |
| Analysts Target Price | 128.7 | 38.2% |
| ValueRay Target Price | 87 | -6.5% |
CHRD Fundamental Data Overview November 11, 2025
P/E Trailing = 29.527
P/S = 1.0247
P/B = 0.6897
Beta = 0.799
Revenue TTM = 5.16b USD
EBIT TTM = 340.0m USD
EBITDA TTM = 1.79b USD
Long Term Debt = 842.6m USD (from longTermDebt, last fiscal year)
Short Term Debt = 24.6m USD (from shortTermDebt, last quarter)
Debt = 1.51b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 880.0m USD (from netDebt column, last quarter)
Enterprise Value = 5.85b USD (4.97b + Debt 1.51b - CCE 629.2m)
Interest Coverage Ratio = 4.80 (Ebit TTM 340.0m / Interest Expense TTM 70.9m)
FCF Yield = 14.78% (FCF TTM 864.8m / Enterprise Value 5.85b)
FCF Margin = 16.75% (FCF TTM 864.8m / Revenue TTM 5.16b)
Net Margin = 3.31% (Net Income TTM 170.6m / Revenue TTM 5.16b)
Gross Margin = 41.97% ((Revenue TTM 5.16b - Cost of Revenue TTM 3.00b) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 14.55%)
Tobins Q-Ratio = 0.45 (Enterprise Value 5.85b / Total Assets 13.10b)
Interest Expense / Debt = 1.24% (Interest Expense 18.7m / Debt 1.51b)
Taxrate = -23.60% (negative due to tax credits) (-40.2m / 170.3m)
NOPAT = 420.2m (EBIT 340.0m * (1 - -23.60%)) [negative tax rate / tax credits]
Current Ratio = 1.35 (Total Current Assets 2.06b / Total Current Liabilities 1.53b)
Debt / Equity = 0.19 (Debt 1.51b / totalStockholderEquity, last quarter 8.07b)
Debt / EBITDA = 0.49 (Net Debt 880.0m / EBITDA 1.79b)
Debt / FCF = 1.02 (Net Debt 880.0m / FCF TTM 864.8m)
Total Stockholder Equity = 8.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.30% (Net Income 170.6m / Total Assets 13.10b)
RoE = 2.04% (Net Income TTM 170.6m / Total Stockholder Equity 8.37b)
RoCE = 3.69% (EBIT 340.0m / Capital Employed (Equity 8.37b + L.T.Debt 842.6m))
RoIC = 4.51% (NOPAT 420.2m / Invested Capital 9.33b)
WACC = 8.47% (E(4.97b)/V(6.48b) * Re(10.58%) + D(1.51b)/V(6.48b) * Rd(1.24%) * (1-Tc(-0.24)))
Discount Rate = 10.58% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 15.20%
[DCF Debug] Terminal Value 70.12% ; FCFE base≈892.3m ; Y1≈919.2m ; Y5≈1.03b
Fair Price DCF = 213.3 (DCF Value 12.13b / Shares Outstanding 56.9m; 5y FCF grow 3.02% → 3.0% )
EPS Correlation: -78.04 | EPS CAGR: -25.50% | SUE: 0.10 | # QB: 0
Revenue Correlation: 75.60 | Revenue CAGR: 9.76% | SUE: 1.69 | # QB: 2
Additional Sources for CHRD Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle